Qube Research & Technologies Ltd

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1729829 LONDON, X0

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$9,482,777

-$7,576,241 QoQ

Shares Held

361,662

-50.1% QoQ

Ownership

0.288%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#52

of 271 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. ARQT ranks #48 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,482,777	361,662	-50.1%	Shares	Sole	2026-08-14
2026-03-31	$17,059,018	724,067	+9.5%	Shares	Sole	2026-05-15
2025-12-31	$19,207,491	661,415	-18.8%	Shares	Sole	2026-02-17
2025-09-30	$15,354,587	814,567	+41.1%	Shares	Sole	2025-11-14
2025-06-30	$8,096,451	577,493	+200.4%	Shares	Sole	2025-08-14
2025-03-31	$3,006,305	192,219	+840.8%	Shares	Sole	2025-05-15
2024-09-30	$190,017	20,432	-97.2%	Shares	Sole	2024-11-14
2023-12-31	$2,344,637	725,894	+5225.3%	Shares	Sole	2024-02-13
2023-06-30	$129,903	13,631	-33.6%	Shares	Sole	2023-08-14
2023-03-31	$225,852	20,532	-64.8%	Shares	Sole	2023-05-15
2022-12-31	$862,603	58,284	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.